Work

CDK12-altered prostate cancer: Clinical features and therapeutic outcomes to standard systemic therapies, PARP inhibitors, and PD1 inhibitors

Year: 2019

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdz248.002

Authors: E.S. Antonarakis, P Isaacsson Velho, N. Agarwal, V Sacristan Santos, B.L. Maughan, R. Pili, N. Adra, C.N. Sternberg, P.J. Vlachostergios, S.T. Tagawa, A.H. Bryce, A.L. McNatty, Z.R. Reichert, R. Dreicer, O. Sartor, T.L. Lotan, M. Hussain

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2977776206

FWCI: 1.811

Cites:

Cited by: 12

Related to: 10